Angireb® - H

Losartan-Hydrochlorothiazide Tablets

Composition

Angireb®-H Tablets

Each film-coated tablet contains:
Losartan Potassium IP 50 mg and
Hydrochlorothiazide IP 12.5 mg

Indications

Hypertension

Angireb®-H is indicated for the treatment of hypertension. This fixed-dose combination is not indicated for initial therapy of hypertension, except when the hypertension is severe enough that the value of achieving prompt blood pressure control exceeds the risk of initiating combination therapy in these patients.

Hypertensive patients with left ventricular hypertrophy

Angireb®-H is indicated to reduce the risk of stroke in patients with hypertension and left ventricular hypertrophy.

PRESENTATION & PACKAGING

Angireb®-H   Yellow, round, biconvex, film-coated tablet
                     Aluminium strip pack of 10 tablets

For Precautions and Drug Interactions please consult full Product Information.

® - Registered Trade Mark of Quality Innovations and Pharmaceuticals (India) Pvt Ltd.

Disclaimer

The drug information is intended for the use of a registered medical practitioner only. If you are not a medical professional, you should note that this document does not provide professional medical advice and is not intended to replace personal consultation with a qualified physician and should not be relied upon solely for final treatment decisions. Company reserves right to change Product presentation, display, capsule colors, tablet size,forms etc without prior notice.